Edwards Lifesciences Corp (EW)
89.14
-0.97
(-1.08%)
USD |
NYSE |
May 17, 16:00
89.15
+0.01
(+0.01%)
After-Hours: 20:00
Edwards Lifesciences Cash from Investing (Quarterly): 63.10M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 63.10M |
December 31, 2023 | 14.10M |
September 30, 2023 | 89.00M |
June 30, 2023 | 70.20M |
March 31, 2023 | 0.50M |
December 31, 2022 | 94.70M |
September 30, 2022 | -201.50M |
June 30, 2022 | 129.60M |
March 31, 2022 | 229.50M |
December 31, 2021 | -965.90M |
September 30, 2021 | -377.40M |
June 30, 2021 | -329.50M |
March 31, 2021 | -49.70M |
December 31, 2020 | -259.90M |
September 30, 2020 | -126.30M |
June 30, 2020 | -10.20M |
March 31, 2020 | -134.70M |
December 31, 2019 | -445.30M |
September 30, 2019 | -12.70M |
June 30, 2019 | -88.30M |
March 31, 2019 | -49.50M |
December 31, 2018 | 5.70M |
September 30, 2018 | -254.20M |
June 30, 2018 | 104.90M |
March 31, 2018 | 220.30M |
Date | Value |
---|---|
December 31, 2017 | 49.30M |
September 30, 2017 | -209.50M |
June 30, 2017 | -638.20M |
March 31, 2017 | 151.20M |
December 31, 2016 | 80.20M |
September 30, 2016 | 3.90M |
June 30, 2016 | -343.10M |
March 31, 2016 | 47.30M |
December 31, 2015 | 27.30M |
September 30, 2015 | -175.60M |
June 30, 2015 | 12.50M |
March 31, 2015 | -180.30M |
December 31, 2014 | 112.00M |
September 30, 2014 | -154.80M |
June 30, 2014 | -470.40M |
March 31, 2014 | -119.80M |
December 31, 2013 | -246.90M |
September 30, 2013 | -106.50M |
June 30, 2013 | -73.00M |
March 31, 2013 | 13.70M |
December 31, 2012 | 27.40M |
September 30, 2012 | -131.90M |
June 30, 2012 | -42.70M |
March 31, 2012 | 68.40M |
December 31, 2011 | -108.30M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-965.90M
Minimum
Dec 2021
229.50M
Maximum
Mar 2022
-115.54M
Average
-31.20M
Median
Cash from Investing (Quarterly) Benchmarks
Stryker Corp | -408.00M |
Align Technology Inc | -79.58M |
Abbott Laboratories | -425.00M |
Boston Scientific Corp | -285.00M |
Steris PLC | -95.61M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -53.50M |
Cash from Financing (Quarterly) | 61.70M |
Free Cash Flow | 251.20M |
Free Cash Flow Per Share (Quarterly) | -0.2298 |
Free Cash Flow to Equity (Quarterly) | -139.00M |
Free Cash Flow to Firm (Quarterly) | -138.80M |
Free Cash Flow Yield | 0.46% |